Duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. Prevention of non-steroidal click at this page drug NSAID including aspirin associated duodenal ulcers, tablets raw in patients with a history of peptic ulcer disease. Chronic ranitidine hcl tablets dyspepsia, characterised by pain epigastric or retrosternal which is related to meals or ranitidine hcl tablets sleep but not associated with ranitidine hcl tablets raw material above conditions.
Before general anaesthesia in patients at risk of acid aspiration Mendelson's syndromeparticularly obstetric patients during labour. Treatment raw material gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease. The standard dosage regimen is mg twice daily or mg at night. It is not necessary to time the dose ranitidine hcl tablets raw material relation to meals.
In most cases of duodenal ulcer, benign gastric ulcer and post-operative ulcer, healing occurs within 4 weeks. Healing usually occurs after a further 4 weeks of treatment in those not fully healed after the initial course of therapy. In duodenal ulcer, ranitidine hcl tablets raw material twice daily for 4 weeks results in healing rates which are higher than those at 4 weeks with ranitidine mg twice daily or mg at night.
The increased dose has not been associated with an increased incidence of unwanted effects. For duodenal ulcers associated with Helicobacter pylori infection, ranitidine mg at bedtime material mg twice daily may be given with oral amoxicillin mg three times daily and metronidazole mg three times daily for two weeks.
Therapy with ranitidine should continue for a ranitidine hcl tablets raw material two weeks. This dose regimen significantly reduces the frequency of duodenal ulcer recurrence.
Maintenance treatment at a reduced dosage of mg at bedtime is recommended for patients who ranitidine hcl tablets responded to short term therapy, particularly those raw material a history of recurrent ulcer. Symptom relief in gastro-oesophageal reflux disease. In patients with gastro-oesophageal reflux disease, ranitidine hcl tablets raw material dose regimen of mg twice daily for 2 weeks is recommended and this can be repeated in patients in whom the initial symptomatic response is inadequate.
In the management of oesophageal reflux disease, the recommended course of treatment is either mg twice click to see more or mg at bedtime material up to 8 weeks or 12 weeks if necessary.
Link patients with moderate to severe oesophagitis, the dosage of ranitidine may be increased to mg 4 times daily for up to 12 weeks.
For long term treatment, recommended adult dose is mg twice daily. Long term treatment is not indicated in management of patients with unhealed oesophagitis with or without Barrett's epithelium. The starting dose for Zollinger-Ellison syndrome is mg three times daily, and this may be increased as necessary.
Doses up to 6 grams per day have been well tolerated. The standard dosage regimen for click the following article with chronic episodic dyspepsia is mg twice daily for up to 6 weeks.
Anyone not responding or relapsing shortly afterwards should be investigated. Prophylaxis of haemorrhage from stress ulceration in seriously ill patients or prophylaxis raw material recurrent haemorrhage in patients bleeding from peptic ulceration:. Alternatively, the injection is also available. In obstetric patients in labour mg material 6 hours, but if general ranitidine hcl tablets raw material is required it is recommended that a non-particulate antacid e.
The usual precautions to avoid acid aspiration should also be taken. For those patients with complete healing, another 4 weeks of therapy is indicated, as healing usually occurs after eight ranitidine hcl tablets raw material ranitidine hcl treatment.
Accordingly, it is recommended that the daily dose of ranitidine in such patients should be mg at night for weeks. The same dose should be material for maintenance treatment, if necessary.
If ranitidine hcl tablets raw material ulcer has not healed after treatment, mg twice ranitidine hcl tablets raw material dosage should be instituted followed, if need be, by maintenance treatment of mg at night.
The possibility of malignancy should be excluded before commencement of therapy in patients with ranitidine hcl tablets ulcer and in patients of middle age and over with new or recently changed dyspeptic symptoms as treatment with ranitidine may raw material symptoms of gastric carcinoma.
Ranitidine is excreted via the kidney and so plasma levels of the drug are increased in patients raw material renal impairment. The dosage should be adjusted as detailed in section 4.
Regular supervision of patients ranitidine hcl tablets are taking non-steroidal anti-inflammatory drugs raw material with tablets raw is recommended, especially in the elderly and in those with a read more of peptic ulcer.
Rare clinical reports suggest that ranitidine may precipitate acute porphyric attacks. Ranitidine should therefore be avoided in patients with a history of acute porphyria.
In patients such as the elderly, persons with chronic raw material disease, diabetes or the immunocompromised, there may be an increased risk of developing community material pneumonia. A large epidemiological study showed an increased risk of developing community acquired pneumonia in current users of ranitidine alone versus those permethrin cream lice had stopped treatment, with an observed adjusted relative risk increase of 1.
Post-marketing data indicate raw material mental confusion, depression, and hallucinations have been reported most frequently in severely ill material elderly patients see section 4. Ranitidine has the potential to affect the absorption, metabolism or renal excretion of other drugs. The altered pharmacokinetics may necessitate dosage adjustment of the affected drug or discontinuation of treatment.
Ranitidine at usual therapeutic doses does not potentiate the actions of drugs which are inactivated by this enzyme system such as diazepam, lidocaine, phenytoin, propanolol and theophylline. There have been reports of altered prothrombin time with coumarin anticoagulants e. Due to the narrow therapeutic ranitidine hcl tablets raw material, close monitoring of increased or decreased prothrombin time is recommended during concurrent treatment with ranitidine.
Since ranitidine is partially eliminated by the raw material system, it may affect the clearance of other drugs eliminated by ranitidine hcl route. High doses of ranitidine e. Ranitidine hcl tablets raw material bioavailability ranitidine hcl tablets raw material certain drugs may be affected.
2018 ©